How Two Chief Medical Officers Are Approaching Diversity & Inclusion
Source: Life Science Leader
In this executive virtual roundtable component, Edith Perez, M.D., chief medical officer at Bolt Biotherapeutics, an immuno-oncology company, discusses how she approaches her D&I in her role. She is joined in the conversation by Peng Lu, M.D., Ph.D., chief medical officer at Pharvaris, a clinical-stage company focused on bringing oral bradykinin B2-receptor antagonists to patients; and Michael McCullar, Ph.D., CEO of OnQuality Pharmaceuticals, an oncology focused drug development company. The full EVR, “Making Diversity & Inclusion A Best Business Practice,” can be viewed here.